Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Narcolepsy.

M M Mitler1, R Hajdukovic, M Erman

  • 1Sleep Disorders Center, Scripps Clinic and Research Foundation, La Jolla, California 92037.

Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PILE: a candidate prognostic score in cancer patients treated with immunotherapy.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021
Same author

In Vitro Fertilization After Renal Transplantation: A Single-Center Experience.

Transplantation proceedings·2019
Same author

Fertility Outcome After Renal Transplantation: A Single-Center Experience.

Transplantation proceedings·2019
Same author

Identification of transcription factors responsible for dysregulated networks in human osteoarthritis cartilage by global gene expression analysis.

Osteoarthritis and cartilage·2018
Same author

Health Related Quality of Life in Cancer Patients: Evaluation With A Self-Administered Ipad Application.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Association of Health Care Cost with Quality of Life for Various Types of Cancers.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

Narcolepsy, a neurological disorder causing sleepiness, is linked to HLA-DR2/DQw1. Treatments like stimulants and tricyclic drugs help manage symptoms such as excessive daytime sleepiness and REM sleep abnormalities.

Area of Science:

  • Neurology
  • Sleep Medicine

Background:

  • Narcolepsy is a neurological disorder affecting up to 1 in 1,000 individuals.
  • Key features include excessive daytime sleepiness and abnormal REM sleep phenomena like cataplexy and sleep paralysis.
  • A strong association exists with the HLA-DR2 and DQw1 genetic markers.

Purpose of the Study:

  • To review the phenomenology and diagnostic procedures for narcolepsy.
  • To discuss current treatment modalities for narcolepsy symptoms.
  • To present findings from sleep laboratory studies on specific narcolepsy medications.

Main Methods:

  • Review of narcolepsy phenomenology and diagnostic criteria.
  • Discussion of pharmacological treatments including CNS stimulants and tricyclic drugs.
  • Presentation of sleep laboratory data on methylphenidate, pemoline, dextroamphetamine, protriptyline, and viloxazine efficacy.

Related Experiment Videos

Main Results:

  • Methylphenidate and dextroamphetamine effectively reduce excessive daytime sleepiness.
  • Pemoline showed limited efficacy for sleepiness but may enhance performance.
  • Protriptyline and viloxazine demonstrated effectiveness in treating cataplexy with minimal impact on sleepiness.

Conclusions:

  • Narcolepsy management involves addressing both excessive daytime sleepiness and REM sleep disturbances.
  • Stimulant medications are effective for somnolence, while tricyclic drugs target REM-related symptoms.
  • Specific drug efficacies vary, with methylphenidate and dextroamphetamine for sleepiness, and protriptyline/viloxazine for cataplexy.